©The Author(s) 2025.
World J Exp Med. Dec 20, 2025; 15(4): 110917
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.110917
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.110917
Figure 2 Images showing different intensities of palmitoyl-protein thioesterase 1 expression in oral squamous cell carcinoma cases (orange arrow denotes the tumor area).
A: Shows 3+ intensity [high intensity of palmitoyl-protein thioesterase 1 (PPT1) antibody in oral squamous cell carcinoma (OSCC) case]; B: Shows 2+ intensity (moderate intensity of PPT1 antibody in OSCC case); C: Shows 1 + intensity (mild intensity of PPT1 antibody in OSCC case); D: Shows no expression of PPT1 antibody in OSCC case.
- Citation: Kumar KCP, Sahoo S, Adhya AK, Gaikwad MR, Ganapathy A, Ravi PK. Evaluating palmitoyl-protein thioesterase 1 in oral squamous cell carcinoma: A novel indicator of tumor behavior and therapeutic response. World J Exp Med 2025; 15(4): 110917
- URL: https://www.wjgnet.com/2220-315x/full/v15/i4/110917.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i4.110917